קסלודה 150 מ"ג

দেশ: ইস্রায়েল

ভাষা: হিব্রু

সূত্র: Ministry of Health

সক্রিয় উপাদান:

CAPECITABINE 150 MG

থেকে পাওয়া:

ROCHE PHARMACEUTICALS (ISRAEL) LTD

এটিসি কোড:

L01BC06

ফার্মাসিউটিকাল ফর্ম:

FILM COATED TABLETS

প্রশাসন রুট:

PER OS

Manufactured by:

HOFFMANN LA ROCHE LTD, SWITZERLAND

থেরাপিউটিক গ্রুপ:

CAPECITABINE

থেরাপিউটিক ইঙ্গিত:

Adjuvant Colon Cancer: Xeloda is indicated for the adjuvant treatment of patients following surgery of stage III (Dukesע stage C) colon cancer. Colorectal Cancer: Xeloda is indicated for the treatment of patients with advanced or metastatic colorectal cancer Advanced gastric cancer: Xeloda is indicated for first line treatment of advanced gastric cancer in combination with chemotherapy Breast Cancer Combination Therapy: Xeloda in combination with docetaxel is indicated for the treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing chemotherapy. Breast Cancer Monotherapy: Xeloda is also indicated for the treatment of advanced or metastatic breast cancer after failure of standard therapy including a taxane unless therapy with a taxane is clinically contraindicated.

অনুমোদন তারিখ:

2010-06-01